P21S10

General Information


DRACP ID  DRACP03994

Peptide Name   P21S10

Sequence  LDLTYEMLSLQQVVKⓍLNEⓍY

Sequence Length  21

UniProt ID  K9N5Q8 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Huh-7 Adult hepatocellular carcinoma; Adult hepatocellular carcinoma Carcinoma CC50>100 μM CCK-8 assay 48 h 1
Calu-3 Lung adenocarcinoma Carcinoma CC50>100 μM CCK-8 assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  46.5

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ are cross-linked by hydrocarbon stapling

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  Ⓧ=(S)-2-(4-pentenyl)alanine

Chiral  L



Physicochemical Information


Formula  C104H163N23O31S

Absent amino acids  ACFGHIPRW

Common amino acids  L

Mass  262056

Pl  3.93

Basic residues  1

Acidic residues  3

Hydrophobic residues  7

Net charge  -2

Boman Index  -1683

Hydrophobicity  1.43

Aliphatic Index  120.48

Half Life 
  /

Extinction Coefficient cystines  2980

Absorbance 280nm  149

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29442512

Title  Discovery of Hydrocarbon-Stapled Short alpha-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15227

DRACP is developed by Dr.Zheng's team.